DNA damage response-related immune activation signature predicts the response to immune checkpoint inhibitors: from gastrointestinal cancer analysis to pan-cancer validation.
Yan J, Wang S, Zhang J, Yuan Q, Gao X, Zhang N, Pan Y, Zhang H, Liu K, Yu J, Lu L, Liu H, Gao X, Zhao S, Zhang W, Reyila A, Qi Y, Zhang Q, Cang S, Lu Y, Pan Y, Kong Y, Nie Y.
Yan J, et al. Among authors: zhang n, zhang q, zhang w, zhang j, zhang h.
Cancer Biol Med. 2023 Dec 29;21(3):252-66. doi: 10.20892/j.issn.2095-3941.2023.0303.
Cancer Biol Med. 2023.
PMID: 38164720
Free PMC article.